Synonyms:
Status: Phase 2
Entry Type: Oligonucleotide
Molecule Category: Parent
UNII: K6KJ8AZ05F

Pharmacology

Action Mechanism of Action Reference
ANTISENSE INHIBITOR p53 mRNA antisense inhibitor PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Leukemia, Myeloid, Acute 2 D015470 ClinicalTrials
Myelodysplastic Syndromes 1 D009190 ClinicalTrials

Related Entries

Salt

Cross References

Resources Reference
CAS NUMBER 415168-49-9
ChEMBL CHEMBL2108280
FDA SRS K6KJ8AZ05F
Guide to Pharmacology 8270